AHCO
HealthcareAdaptHealth Corp. · Medical - Devices · $1B
What is AdaptHealth Corp.?
AdaptHealth Corp. is a US-based provider of home medical equipment and supplies, serving patients covered by Medicare, Medicaid, and commercial insurance across the country.
AdaptHealth delivers equipment and supplies directly to patients at home. Revenue comes primarily from insurance reimbursements for sleep therapy devices, diabetes management tools, oxygen therapy, and other chronic-care supplies. The company acts as a distribution and service layer between manufacturers, clinicians, and patients who need ongoing home-based care.
Founded in 2018 and headquartered in Plymouth Meeting, Pennsylvania.
- Sleep therapy equipment and CPAP/BiPAP services
- Continuous glucose monitors and insulin pumps
- Home oxygen and chronic respiratory therapy
- Wound care, ostomy, and incontinence supplies
Is AHCO a Good Stock to Buy?
UQS Score rates AHCO as Below Average overall.
The one area where AHCO stands out is Valuation, which is rated Attractive — suggesting the market may already be pricing in the company's challenges.
Quality, Moat, Growth, and Risk all carry Weak ratings, reflecting meaningful structural and operational headwinds across the business.
See the full pillar breakdown and underlying financial metrics by signing up for a Pro account at UQS Score. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does AHCO pay dividends?
No — AdaptHealth Corp. does not currently pay a dividend.
AHCO does not currently pay a dividend. Given the company's weak profitability and risk profile, capital is not being returned to shareholders in this form. Investors seeking income would need to look elsewhere in the healthcare sector.
When does AHCO report earnings?
AdaptHealth reports earnings on a quarterly cadence, consistent with standard US-listed equity practice.
The company operates in a reimbursement-driven model, making quarterly results sensitive to payor mix shifts and regulatory changes. Performance trends across recent periods reflect the broader challenges captured in the weak pillar ratings.
For the most recent quarter's results, visit AdaptHealth's investor relations page directly.
AHCO Price History
-53.6% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in AdaptHealth Corp.?
Based on AdaptHealth Corp.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
Frequently Asked Questions
What does AdaptHealth Corp. do?
AdaptHealth provides home medical equipment and supplies to patients across the US. Its core services include sleep therapy, diabetes device management, home oxygen, and chronic-care supplies — all billed through Medicare, Medicaid, or commercial insurance.
Does AHCO pay dividends?
No, AHCO does not pay a dividend. The company currently retains any available capital rather than distributing it to shareholders, which is common among smaller healthcare services companies with ongoing operational pressures.
When does AHCO report earnings?
AdaptHealth follows a standard quarterly earnings schedule. For exact upcoming dates, check the company's investor relations page, as our data source does not publish forward earnings dates.
Is AHCO a good stock to buy?
The UQS Score rates AHCO as Below Average. While Valuation is Attractive, the Quality, Moat, Growth, and Risk pillars are all Weak. That combination warrants careful consideration. The full pillar detail is available to Pro members.
Is AHCO overvalued?
Based on UQS scoring, AHCO's Valuation pillar is rated Attractive, meaning the stock does not appear expensive relative to its fundamentals. However, low valuations can reflect genuine business risk rather than a hidden opportunity.
Is AHCO a long-term quality indicator?
As a long-term quality indicator, AHCO scores poorly across most pillars. Weak ratings in Quality, Moat, and Growth suggest the business lacks the durable characteristics typically associated with compounding long-term returns.
What sector does AHCO belong to?
AHCO operates in the Healthcare sector, specifically within home medical equipment and chronic-care supply services. It sits at the intersection of healthcare delivery and insurance reimbursement.
What is AHCO's market cap bracket?
AHCO is classified as a small-cap stock. This places it in a segment of the market that can carry higher volatility and liquidity risk compared to large- or mega-cap healthcare peers.
Unlock Full AHCO Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the exact UQS Score and all five pillar scores
- ✓Access underlying financial metrics driving each rating
- ✓Compare AHCO against sector peers on a standardized scorecard
- ✓Get the complete analyst-style quality breakdown in one place
Pro Analysis
AHCO — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 23, 2026 | 38.4 | 29.8 | 27.0 | 37.9 | 14.5 | 96.6 | -0.1 |
| May 22, 2026 | 38.5 | 29.8 | 27.0 | 37.9 | 14.5 | 97.1 | 0.0 |
| May 20, 2026 | 38.5 | 29.8 | 27.0 | 37.9 | 14.5 | 97.3 | 0.0 |
| May 17, 2026 | 38.5 | 29.8 | 27.0 | 37.9 | 14.5 | 96.8 | 0.0 |
| May 16, 2026 | 38.5 | 29.8 | 27.0 | 37.9 | 14.5 | 97.3 | -0.1 |
| May 14, 2026 | 38.6 | 29.8 | 27.0 | 37.8 | 14.5 | 97.9 | -0.1 |
| May 11, 2026 | 38.7 | 29.8 | 27.0 | 37.8 | 14.5 | 98.7 | -0.5 |
| May 7, 2026 | 39.2 | 30.5 | 27.0 | 37.7 | 16.7 | 98.9 | +0.2 |
| May 3, 2026 | 39.0 | 30.5 | 27.0 | 37.7 | 16.7 | 97.4 | -0.1 |
| May 2, 2026 | 39.1 | 30.5 | 27.0 | 37.7 | 16.7 | 98.0 | 0.0 |
AHCO — Pillar Breakdown
Quality
— 29.8/100 (25%)AdaptHealth Corp. currently shows below-average quality metrics, suggesting challenges with profitability.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 37.9/100 (20%)AdaptHealth Corp. shows steady but unspectacular growth, typical for mature companies.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 14.5/100 (15%)AdaptHealth Corp. presents elevated risk with concerns around leverage or financial stability.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 97.4/100 (15%)AdaptHealth Corp. appears attractively valued relative to its earnings, cash flows, and sector peers.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 27/100 (25%)AdaptHealth Corp. operates in a highly competitive environment with limited sustainable advantages. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for AHCO.
Score Composition
Financial Data
More Stock Analysis
How is the AHCO UQS Score Calculated?
The UQS (Unified Quality Score) for AdaptHealth Corp. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses AdaptHealth Corp.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether AdaptHealth Corp. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.